BIOMAT Database Logo BIOMAT Database Logo

Insulin receptor of erythrocytes and glucose metabolism in uremic children. 1983

T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
[Aspects of glucose metabolism of erythrocytes in uremic subjects].
January 1970, Minerva nefrologica,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects.
October 1970, The Journal of laboratory and clinical medicine,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
[Radioimmunologic analysis of insulin (IRI) in glucose metabolism in uremic patients].
August 1989, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Impaired metabolism of deoxyadenosine in uremic erythrocytes.
January 1984, Advances in experimental medicine and biology,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Lifespan and glucose metabolism in insulin receptor mutant mice.
January 2011, Journal of aging research,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors.
July 1991, The American journal of physiology,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
The PMA action via metabolism of uremic erythrocytes.
January 2015, Clinical hemorheology and microcirculation,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Glucose metabolism of mammalian erythrocytes.
October 1976, Journal of cellular physiology,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.
April 2004, European journal of pharmacology,
T Namikawa, and T Namikawa, and S Fujimoto, and A Furuse, and S Hattori, and I Matsuda, and C Nakahara, and H Ito
Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
January 1983, Nephron,
Copied contents to your clipboard!